Duke Proteomics Core - Skyline for Small Molecules

Duke Proteomics Core - Skyline for Small Molecules
Skyline for Small Molecules: A Unifying Software Package for Quantitative Metabolomics
  • Organism: Homo sapiens, Mus musculus
  • Instrument: Xevo TQ-S,Triple Quad 5500,Synapt G2 HDMS
  • SpikeIn: Yes
  • Keywords: Skyline, Small Molecules, Metabolomics, Pharmacokinetics, Quantification, Mass Spectrometry, Selected Reaction Monitoring, Targeted Mass Spectrometry, High-Resolution, Untargeted Mass Spectrometry
  • Lab head: Will Thompson Submitter: Will Thompson
Abstract
Vendor-independent software tools for quantification of small molecules and metabolites are lacking, especially for targeted analysis workflows. Skyline is a freely available, open-source software tool for quantitative mass spectrometry method development and data processing with a ten-year history supporting 6 major instrument vendors. Designed initially for proteomic analysis, we describe the expansion of Skyline to data for small molecule analysis, including selected reaction monitoring (SRM), high-resolution mass spectrometry (HRMS), and calibrated quantification. This fundamental expansion of Skyline from a peptide-sequence centric tool to a molecule-centric tool makes it agnostic to the source of the molecule while retaining Skyline features critical for workflows in both peptide and more general biomolecular research. The data visualization and interrogation features already available in Skyline - such as peak picking, chromatographic alignment, and transition selection - have been adapted to support small molecule data, including metabolomics. Herein, we explain the conceptual workflow for small molecule analysis using Skyline, demonstrate Skyline performance benchmarked against a comparable instrument vendor software tool, and present additional real-world applications. Further, we include step-by-step instructions on using Skyline for small molecule quantitative method development and data analysis on data acquired with a variety of mass spectrometers from multiple instrument vendors.
Experiment Description
Various experiments to demonstrate the performance of Skyline for small molecule quantification, including SRM analyses, SRM method development, positive/negative switching SRM, and high-resolution MS1 quantification.
Sample Description
Brain tissue, urine, plasma, cell culture lysates
Created on 8/22/19, 9:58 PM
Clustergrammer Heatmap
 
Download
Eclipse_DIA_HeLa_dilutions_2022-09-21_16-38-15.sky.zip2022-09-21 18:01:035,43933,836033,8361,433,574110
Ebhardt_CorrAnalysis_MRM_data_2022-08-31_14-52-01.sky.zip2022-09-05 14:50:369901872240
AutoQC_2022-08-30_13-27-51.sky.zip2022-08-30 10:28:299051741452851
iBAQ_Skyline_Relative_Quantitation_TEP_Orbitrap.sky.zip2022-08-23 14:39:001353053159210
SIDA_Absolute_Quantitation_TEP_Vantage.sky.zip2022-08-23 14:37:431221042182280
SIDA_Absolute_Quantitation_Abic_Vantage.sky.zip2022-08-23 14:37:431220040150280
EV-Exp12-ADPD-RegLib_2022-06-23_21-24-46.sky.zip2022-08-22 13:21:232,29914,863014,863128,0504814,863
Plasma-Exp12-ADPD-QuantResults_2022-07-25_12-19-55.sky.zip2022-08-22 12:47:2966710,115010,11588,229480
Eclipse-System-Suitability-TPAD-plate5.sky.zip2022-08-21 18:06:552170171212017
Eclipse-System-Suitability-TPAD-plate4.sky.zip2022-08-21 18:03:142170171212617
Eclipse-System-Suitability-TPAD-plate3B.sky.zip2022-08-21 17:57:492170171211917
Eclipse-System-Suitability-TPAD-plate3A.sky.zip2022-08-21 17:53:252170171212317
Eclipse-System-Suitability-TPAD-plate2B.sky.zip2022-08-21 17:48:172170171212017
Eclipse-System-Suitability-TPAD-plate2A.sky.zip2022-08-21 17:44:012170171212517
Eclipse-System-Suitability-TPAD-plate1B.sky.zip2022-08-21 17:38:162170171211517
Eclipse-System-Suitability-TPAD-plate1A.sky.zip2022-08-21 17:30:362170171211817
TPAD_CSF_Plate5_Enolase_PRTC_Contaminants.sky.zip2022-08-21 17:19:18633033260600
TPAD_CSF_Plate4_Enolase_PRTC_Contaminants.sky.zip2022-08-21 17:18:23633033260480
TPAD_CSF_Plate3B_Enolase_PRTC_Contaminants.sky.zip2022-08-21 17:17:06633033260480
TPAD_CSF_Plate3A_Enolase_PRTC_Contaminants.sky.zip2022-08-21 17:15:37739040328480
TPAD_CSF_Plate2B_Enolase_PRTC_Contaminants.sky.zip2022-08-21 17:14:03739040328480
TPAD_CSF_Plate2A_Enolase_PRTC_Contaminants.sky.zip2022-08-21 17:12:09739040328480
TPAD_CSF_Plate1B_Enolase_PRTC_Contaminants.sky.zip2022-08-21 17:10:29739040328480
TPAD_CSF_Plate1A_Enolase_PRTC_Contaminants.sky.zip2022-08-21 17:05:10739040328480
TPAD_CSF1B-SP3plate.sky.zip2022-08-01 15:00:361,5248,03508,03561,935480
TPAD-CSF-SP3plate-1A.sky.zip2022-08-01 12:51:181,5358,30808,30863,697480
TPAD_CSF4-SP3plate.sky.zip2022-08-01 10:14:301,4607,99007,99061,116480
TPAD_CSF3B-SP3plate.sky.zip2022-08-01 10:01:321,4758,10108,10162,125480
TPAD_CSF3A-SP3plate.sky.zip2022-08-01 09:50:291,4677,62207,62258,452480
TPAD_CSF2B-SP3plate.sky.zip2022-08-01 09:37:461,5778,60008,60066,201480
TPAD_CSF2A-SP3plate.sky.zip2022-08-01 09:23:061,6619,26609,26671,094480
plasma-EV-01_2022-07-06_10-10-22.sky.zip2022-07-29 17:58:434,03032,915032,915342,85810
22052022_PitAdenoma_AcroCush_VS_Control_2022-07-07_16-02-57.sky.zip2022-07-07 13:18:41633033200280
Pluripotent human iPSC Markers-LINCS_2020-11-12_12-19-38.sky.zip2022-06-27 21:41:16732,52602,32414,44560
Final_P108_12_03_scheduledPRM_34prec_refined_2021-11-29_15-28-50.sky.zip2022-06-24 13:32:35633034201160
20220609_cd1d_2022-06-13_14-26-16.sky.zip2022-06-13 09:50:12120420840
Titration_2022-05-31_14-01-51.sky.zip2022-06-08 10:18:2812021570
Patient9_2022-05-31_13-59-34.sky.zip2022-06-08 10:18:28120316290
Patient8_2022-05-31_13-59-00.sky.zip2022-06-08 10:18:28130318320
Patient7_2022-05-31_13-58-24.sky.zip2022-06-08 10:18:28130315180
Patient6_2022-05-31_13-57-55.sky.zip2022-06-08 10:18:28120218260
Patient5_2022-05-31_13-57-07.sky.zip2022-06-08 10:18:28120212360
Patient4_2022-05-31_13-55-39.sky.zip2022-06-08 10:18:2811015300
Patient3_2022-05-31_13-55-01.sky.zip2022-06-08 10:18:2811016320
Patient2_2022-05-30_17-02-16.sky.zip2022-06-08 10:18:28120211110
Patient1_2022-05-27_13-48-49.sky.zip2022-06-08 10:18:2812029340
191129GA_FTIR-Lipids_Plasma_dMRM_2022-05-25_10-58-12.sky.zip2022-05-25 07:55:581702662662661080
20220428-covid-panorama_2022-05-07_18-15-53.sky.zip2022-05-09 21:51:28240742500
220124_PrEST_Assays_ArgC_select_top10_2022-05-03_14-29-07.sky.zip2022-05-03 22:41:021038038375200
220124_PrEST_Assays_Trypsin_select_top10_2022-05-03_14-27-38.sky.zip2022-05-03 22:40:581114501451,349200
220124_PrEST_Assays_GluC_select_top10_2022-05-03_14-02-14.sky.zip2022-05-03 22:40:38111050105986200
220124_PrEST_Assays_Chymotrypsin_select_top10_2022-05-03_13-12-26.sky.zip2022-05-03 22:40:331197097909200
220124_PrEST_Assays_Lysarginase_select_top10_2022-05-03_12-52-37.sky.zip2022-05-03 22:40:281112901291,227200
220124_PrEST_Assays_LysC_select_top10_2022-05-03_10-40-54.sky.zip2022-05-03 22:40:231177077710200
211119_AllTargets_Trypsin_select_top10_quantification_cleaned_top5_2022-01-31_14-43-11.sky.zip2022-05-03 22:40:1952605225490
211103_AllTargets_LysC_select_top10_quantification_cleaned_top5_2022-01-31_14-37-29.sky.zip2022-05-03 22:38:4841102211090
211108_AllTargets_Lysarginase_select_top10_quantification_Cleaned_top5_2022-01-31_14-33-00.sky.zip2022-05-03 22:38:2031803618090
211123_AllTargets_GluC_select_top10_quantification_cleaned_top5_2022-01-31_14-25-37.sky.zip2022-05-03 22:37:49460125490
211123_AllTargets_Chymotrypsin_select_top10_quantification_cleaned_top5_2022-01-31_14-21-55.sky.zip2022-05-03 22:34:58480167090
211108_AllTargets_ArgC_select_top10_quantification_cleaned_top5_2022-01-31_14-11-04.sky.zip2022-05-03 22:34:5832042090
Fig4BtoD_centroid_CIA_PRM_v3_MS2only_unique_protein_5640_9606_20190515_v1.1_2022-04-27_17-08-05.sky.zip2022-04-28 16:03:101027028183100
Fig1C_centroid_CIA_PRM_v5_MS2only_unique_protein_5640_9606_20210910_v1.1_2022-04-27_15-57-33.sky.zip2022-04-28 16:03:101546048297100
Fig2B_centroid_CIA_PRM_v4_MS2only_unique_protein_5640_9606_IOP1_20200214_v1.1_2022-04-27_15-36-21.sky.zip2022-04-28 16:03:1061601613540
Skyline10052021_2022-04-19_14-03-32.sky.zip2022-04-21 11:57:301552095752780
SkylineCalibrationCurve_2022-04-19_13-17-38.sky.zip2022-04-21 11:57:301554099784170
AutoQC_PVV_2021-09-27_11-57-07.sky.zip2022-04-14 20:11:555550561681610
210311_Flo1Lipids_dMRM_DoseResponse-Expt2_2022-02-15_18-10-14.sky.zip2022-04-07 21:11:19210572572575110
200907_Flo1Lipids_dMRM_DoseResponse-Expt1_2022-02-15_18-08-50.sky.zip2022-04-07 21:11:19210551551554140
Cohort_4_male2022-03-29 14:21:481022044173390
Cohort_4_female2022-03-29 14:21:481022044173390
Cohort_3_male2022-03-29 14:21:481022044173380
Cohort_3_female2022-03-29 14:21:481022044173390
Cohort_2_male2022-03-29 14:21:481022044173420
Cohort_2_female2022-03-29 14:21:481022044173420
Cohort_1_wd2022-03-29 14:21:481022044173390
Cohort_1_chow2022-03-29 14:21:481022044173390
20200818_Clinical_Samples PAPER_2021-07-06_11-00-17.sky.zip2022-03-24 07:36:2969018106200
20200218_LLOQ21.9 FS PAPER_2021-07-06_10-49-57.sky.zip2022-03-24 07:36:298110221464811
20200318_LLOQ 23.8 nFS PAPER_2021-07-06_10-31-16.sky.zip2022-03-24 07:36:298110221464811
20200512_LLOQ24.6_FS PAPER_2021-07-06_10-29-06.sky.zip2022-03-24 07:36:298110221424811
20200514_LLOQ 25.8 noFS PAPER_2021-07-06_10-01-52.sky.zip2022-03-24 07:36:298110221464811
VEP_new12mz_B_2022-03-21_18-20-02.sky.zip2022-03-21 18:27:153,15119,092019,092112,11860
VEP_newmeth_12mz_2022-03-21_12-02-18.sky.zip2022-03-21 12:09:333,35619,822019,822115,41960
VEP_dorameth_8mz_2022-03-21_11-53-18.sky.zip2022-03-21 12:01:302,88215,624015,62483,07760
13-tSIM-PRM_ACO3-Ser91_UV-B_11d_Fig8D.sky.zip2022-03-14 21:11:16120310960
12-tSIM-PRM_ACO3-Ser91_aco3-ox-3_UV-B-24h_Fig6C.sky.zip2022-03-14 21:11:15120367110
10-tSIM-PRM_ACO3-Ser91_CHX_UV-B-24h_Fig5B.sky.zip2022-03-14 21:11:14120386110
XW0003-Oremo-OmBcells_min_2020-05-06_10-39-00.sky.zip2022-03-09 20:46:193,04413,645013,64572,720200
CACTI_HDL_proteomics_15N_APOA1_2022-02-23_11-00-35.sky.zip2022-02-23 18:01:53110281810
CACTI_HDL_proteomics_2022-02-23_10-18-16.sky.zip2022-02-23 18:01:5380800829501810
SFTPB_fractions_otherproteins_2022-02-23_10-06-14.sky.zip2022-02-23 18:01:531212012191500
SFTPB_fractions_ProSFTPB_2022-02-23_10-00-48.sky.zip2022-02-23 18:01:531901079500
SFTPB_fractions_13C6_15N4_2022-02-23_09-55-10.sky.zip2022-02-23 18:01:53220672500
SFTPB_fractions_15N-APOA1_2022-02-23_09-49-15.sky.zip2022-02-23 18:01:53220448500
20220223_IFI16-KO_HSV1_PRM_Panorama_2022-02-23_16-08-22.sky.zip2022-02-23 17:07:276014301431,964180
Manes TLR Chemotaxis 2022.sky.zip2022-02-16 00:10:13728105957,456190
211221_(d)PSM_analysed01_2022-02-14_12-26-42.sky.zip2022-02-14 22:13:27532032132310
20210927_LeRoch Karine Batch 2 PfRAP01_72_80hrs_2022-02-05_18-12-10.sky.zip2022-02-07 17:24:1410115119222160
20210926 LeRoch Karine Batch-1 PfRAP21_72_80hrs_2022-02-05_18-11-03.sky.zip2022-02-07 17:24:09107676145160
20190729Malaria_Protein_PfRAP01_and_PfRAP21_56hrs_pos_2022-02-05_18-10-29.sky.zip2022-02-07 17:24:046506565127200

This data is available under the CC BY 4.0 license.